SEC Comment Letter 0000000000-22-013811 to LianBio (LIANY) (CIK 0001831283) (LIANY)
LianBio (LIANY) (CIK 0001831283)
Date: Dec. 22, 2022 · CIK: 0001831283 · Accession: 0000000000-22-013811
AI Filing Summary & Sentiment
File numbers found in text: 333-268317
Letter
United States securities and exchange commission logo December 22, 2022 Angela Chen Vice President, Legal LianBio 103 Carnegie Center Drive, Suite 309 Princeton, NJ 08540 Re:LianBio Amendment No. 1 to Registration Statement on Form S-3 Filed December 9, 2022 File No. 333-268317 Dear Angela Chen: We have reviewed your amended registration statement and have the following comments. In some of our comments, we may ask you to provide us with information so we may better understand your disclosure. Please respond to this letter by amending your registration statement and providing the requested information. If you do not believe our comments apply to your facts and circumstances or do not believe an amendment is appropriate, please tell us why in your response. After reviewing any amendment to your registration statement and the information you provide in response to these comments, we may have additional comments. Unless we note otherwise, our references to prior comments are to comments in our November 28, 2022 letter. Amendment No. 1 to Registration Statement on Form S-3 Cover Page 1.We note your revisions in response to prior comment 1. Please disclose prominently on the prospectus cover page that you are not a Chinese operating company but a Cayman Islands holding company with operations conducted by your subsidiaries. 2.We note your revisions in response to prior comment 5. On the Cover Page, please provide a cross-reference to the consolidated financial statements.
FirstName LastNameAngela Chen Comapany NameLianBio December 22, 2022 Page 2 FirstName LastName Angela Chen LianBio December 22, 2022 Page 2 Please contact Jimmy McNamara at 202-551-7349 or Joe McCann at 202-551-6262 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Thomas J. Danielski
Show Raw Text
United States securities and exchange commission logo
December 22, 2022
Angela Chen
Vice President, Legal
LianBio
103 Carnegie Center Drive, Suite 309
Princeton, NJ 08540
Re:LianBio
Amendment No. 1 to Registration Statement on Form S-3
Filed December 9, 2022
File No. 333-268317
Dear Angela Chen:
We have reviewed your amended registration statement and have the following
comments. In some of our comments, we may ask you to provide us with information so we
may better understand your disclosure.
Please respond to this letter by amending your registration statement and providing the
requested information. If you do not believe our comments apply to your facts and
circumstances or do not believe an amendment is appropriate, please tell us why in your
response.
After reviewing any amendment to your registration statement and the information you
provide in response to these comments, we may have additional comments. Unless we note
otherwise, our references to prior comments are to comments in our November 28, 2022 letter.
Amendment No. 1 to Registration Statement on Form S-3
Cover Page
1.We note your revisions in response to prior comment 1. Please disclose prominently on
the prospectus cover page that you are not a Chinese operating company but a Cayman
Islands holding company with operations conducted by your subsidiaries.
2.We note your revisions in response to prior comment 5. On the Cover Page, please
provide a cross-reference to the consolidated financial statements.
FirstName LastNameAngela Chen
Comapany NameLianBio
December 22, 2022 Page 2
FirstName LastName
Angela Chen
LianBio
December 22, 2022
Page 2
Please contact Jimmy McNamara at 202-551-7349 or Joe McCann at 202-551-6262 with
any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc: Thomas J. Danielski